2024

Memory B cells anticipate SARS-CoV-2 variants through somatic hypermutation

Bruhn M, Obara M, Chiyyeadu A, Costa B, Salam A, Ziegler A, Waltl I, Pavlou A, Bonifacius A, Hoffmann M, Graalmann T, Pöhlmann S, Eiz-Vesper B, Schambach A, Kalinke U

Published in

The Journal of Infection: Volume 88, Issue 1, Page 57-60

Cite this publication

DOI: 10.1016/j.jinf.2023.10.020

PubMed

Authors

Dr. Dr. Theresa Graalmann

Junior Group Leader

Dr. Annett Ziegler

Postdoctoral Researcher

Dr. Matthias Bruhn

Postdoctoral Researcher

Dr. Andreas Pavlou

Postdoctoral Researcher

Abdus Salam

PhD Student

Prof. Dr. Ulrich Kalinke

Executive Director

Inken Waltl, PhD

Postdoctoral Researcher

Alumni

Maureen Obara

PhD Student (ZIB Program)

Associated labs

Kalinke Lab

Experimental Infection Research

Graalmann Lab

Translational Immunology

Associated project

Platform for the rapid development of new pathogen-directed humanized or fully human monoclonal antibody candidates (MEMUMAB)

Monoclonal antibodies are transforming modern medicine. At Helmholtz Infection Medicine Hannover, uniting TWINCORE and CiiM, cutting-edge technologies and AI drive the development of next-generation human antibodies targeting major infectious diseases.